Laurion Capital Management’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-15,007
Closed -$110K 476
2023
Q3
$110K Buy
+15,007
New +$125K ﹤0.01% 447
2020
Q1
Sell
-11,912
Closed -$191K 737
2019
Q4
$191K Buy
+11,912
New +$182K ﹤0.01% 826
2019
Q1
Sell
-13,945
Closed -$281K 837
2018
Q4
$281K Buy
+13,945
New +$289K 0.01% 868
2018
Q2
Sell
-16,285
Closed -$281K 1310
2018
Q1
$281K Sell
16,285
-2,015
-11% -$33.6K ﹤0.01% 1148
2017
Q4
$305K Buy
+18,300
New +$312K ﹤0.01% 1322
2017
Q2
Sell
-12,800
Closed -$222K 1610
2017
Q1
$222K Buy
+12,800
New +$214K ﹤0.01% 1160

Other funds holding ANGO

Laurion Capital Management's ANGO Position: Q4 2023 in Review

Laurion Capital Management sold out of AngioDynamics (ANGO) in Q4 2023, closing a stake of 15,007 shares — an estimated $110K sold.

Laurion Capital Management first reported a position in ANGO in Q1 2017 and held it in 6 quarters. The position peaked at $305K in Q4 2017. 150 funds tracked by Wall St. Rank hold ANGO as of Q4 2023.

  • Laurion Capital Management reported no remaining AngioDynamics position as of Q4 2023 after selling out during the quarter.
  • Laurion Capital Management sold 15,007 AngioDynamics shares in Q4 2023, an estimated $110K.
  • Laurion Capital Management first reported a position in AngioDynamics in Q1 2017 and held it in 6 quarters.
  • Laurion Capital Management's AngioDynamics position peaked at $305K in Q4 2017.
  • 150 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2023.

Based on Laurion Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.